|
 |
| Patents |
|
| 1. Recombinant infectious bovine rhinotracheitis virus mutant, methods for the production of same, and vaccines containing the same. Rebordosa, X.; Piñol, J.; Pérez-Pons, J.A.; Lloberas, J.; Naval, J.; Espuña, E.; Querol, E. Patent P9400172. Priority: ESP Date of filing: january 31, 1994. Applicant: LHIP - Laboratorios Hipra, S.A. Designated States: FRA GBR DEU ITA GRC SWE USA |
|
| 2. Procedure for the production in recombinant form of antigens of glycoprotein gE of bovine type 1 herpesvirus and its use in serological differentiation between infected and vaccinated animals. Rebordosa, X.; Piñol, J.; Pérez-Pons, J.A.; Lloberas, J.; Naval, J.; Espuña, E.; Querol, E. Patent P9500180. Priority: ESP Date of filing: febraury 1, 1995. Applicant: LHIP - Laboratorios Hipra, S.A. Designated States: FRA GBR DEU ITA GRC SWE USA |
|
| 3. Nucleic acids encoding transcriptional activators. R.A. Maki, M. Klemsz, S. McKercher y A. Celada. Patent # 5,734,036, March 31, 1998. The Burnham Institute, La Jolla, California. |
|
| 4. Methods controlling the proliferation of macrophages. R. A. Maki y A. Celada. Patente # P31 9091 (Patent pending). The Burnham Institute, La Jolla, California. |
|
| 5. Repression of MHC class II antigen expression. A. Celada y R.A. Maki, Patente # P 38 5435 (Patent pending) The Burnham Institute, La Jolla California. |
|
|
|
|
|
|
|
|
|
Contact us